NASDAQ:SVA | Free Cash Flow | SINOVAC BIOTECH LTD

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$512.18M$48.92M-$561.1M
2024-12-31-$56.89M$95.96M-$152.85M-375.96%
2023-12-31$138.65M$156.17M-$17.52M
2022-12-31-$798.12M$313.86M-$1.11B-7686.27%
2021-12-31$15.32B$594.21M$14.73B181.33%
2020-12-31$479.31M$127.49M$351.82M318.77%
2019-12-31$39.07M$10.63M$28.45M63.31%
2018-12-31$7.94M$5.61M$2.33M10.70%
2017-12-31$59.76M$11.92M$47.84M185.38%
2016-12-31-$13.9M$12.65M-$26.56M
2015-12-31$4.21M$5.3M-$1.09M
2014-12-31-$10.13M$10.91M-$21.04M
2013-12-31$5.58M$5.13M$443,000.005.95%
2012-12-31-$16.25M$16.16M-$32.41M
2011-12-31$13.94M$15.46M-$1.52M
2010-12-31-$14.28M$24.82M-$39.1M
2009-12-31$48.41M$4.32M$44.09M220.92%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.